Ligand Pharmaceuticals Incorporated (LGND)
Jul 2, 2025 - LGND was delisted (reason: merged into PTHS)
113.30
+0.74 (0.66%)
Inactive · Last trade price on Jul 2, 2025
Ligand Pharmaceuticals Employees
Ligand Pharmaceuticals had 68 employees as of December 31, 2024. The number of employees increased by 10 or 17.24% compared to the previous year.
Employees
68
Change (1Y)
10
Growth (1Y)
17.24%
Revenue / Employee
$2,758,588
Profits / Employee
-$1,115,647
Market Cap
3.48B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 68 | 10 | 17.24% |
| Dec 31, 2023 | 58 | -18 | -23.68% |
| Dec 31, 2022 | 76 | -78 | -50.65% |
| Dec 31, 2021 | 154 | -1 | -0.65% |
| Dec 31, 2020 | 155 | 40 | 34.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
LGND News
- 5 days ago - Ligand to Report Third Quarter 2025 Financial Results on November 6, 2025 - GlobeNewsWire
- 12 days ago - Ligand to Host Investor Day on December 9, 2025 - GlobeNewsWire
- 19 days ago - Ligand Partner SQ Innovation Receives FDA Approval for Lasix® ONYU, an At-Home Treatment for Edema in Heart Failure Patients - GlobeNewsWire
- 4 weeks ago - Arecor announces Co-development Agreement with US Insulin Pump Device Company for AT278 & Sale of Royalty Rights and Technology Access Fees for AT220 and AT292 - GlobeNewsWire
- 2 months ago - Ligand to Participate in September Investor Conferences - GlobeNewsWire
- 2 months ago - Ligand Announces Closing of Convertible Senior Notes Offering - GlobeNewsWire
- 2 months ago - Ligand Announces Pricing of $400 Million Convertible Senior Notes Offering - GlobeNewsWire
- 2 months ago - Ligand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030 - GlobeNewsWire